Skip to content

CEN BIOTECH, INC.: 10-Q filed 2021-11-19

What CEN BIOTECH, INC. reported in its quarterly report filed 2021-11-19 (fiscal Q3 2021): 39 published measures, 98 facts as tagged in accession 0001437749-21-027166.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-19
Fiscal period
fiscal Q3 2021
Accession
0001437749-21-027166 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CEN BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-308,401,965USD
At 2020-12-316,314,142USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3011,481,732USD
At 2020-12-3116,305,859USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-30-3,079,767USD
At 2021-06-30-4,978,795USD
At 2020-12-31-9,991,717USD
At 2020-09-30-29,345,981USD
At 2020-06-30-27,816,555USD
At 2019-12-31-25,535,162USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-30213,805USD
At 2020-12-311,908USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-718,940USD92
2021-01-01 to 2021-09-30-16,835,140USD273
2020-07-01 to 2020-09-30-1,926,176USD92
2020-01-01 to 2020-09-30-4,886,169USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-256,032USD273
2020-01-01 to 2020-09-30-399,306USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-3018,988USD273
2020-01-01 to 2020-09-300USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-30272,166USD92
2021-01-01 to 2021-09-30272,166USD273
2016-03-01 to 2021-07-080USD1956
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-30410,830USD273
2020-01-01 to 2020-09-30499,000USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-3066,731USD273
2020-01-01 to 2020-09-30-103,199USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-43,895,667USD
At 2020-12-31-27,060,527USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-30103,825USD
At 2020-12-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-07-01 to 2021-09-3075,750USD92
2021-01-01 to 2021-09-3015,077,072USD273
2020-07-01 to 2020-09-30196,650USD92
2020-01-01 to 2020-09-30589,950USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-644,976USD92
2021-01-01 to 2021-09-30-17,253,393USD273
2020-07-01 to 2020-09-30-968,424USD92
2020-01-01 to 2020-09-30-2,189,621USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-30396,906USD
At 2020-12-3119,809USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3010,871,100USD
At 2020-12-3114,705,757USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30283,694USD
At 2020-12-31190,716USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-09-301,127,857USD
At 2020-12-310USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-09-305,278,867USD
At 2020-12-314,956,147USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-30164,407USD
At 2020-12-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-30917,142USD92
2021-01-01 to 2021-09-3017,525,559USD273
2020-07-01 to 2020-09-30968,424USD92
2020-01-01 to 2020-09-302,189,621USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3047,786,013shares
At 2020-12-3127,557,363shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3040,860,279USD
At 2020-12-3117,068,810USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-09-30-44,379USD
At 2020-12-310USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30150,323USD
At 2020-12-310USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30318,775USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-30114,682USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-3010,857USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-305,278,867USD
At 2020-12-314,956,147USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-30829,266USD
At 2020-12-31641,023USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-3018,694USD
At 2020-12-310USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2021-09-300USD
At 2020-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-763,319USD92
2021-01-01 to 2021-09-30-16,879,519USD273
2020-07-01 to 2020-09-30-1,926,176USD92
2020-01-01 to 2020-09-30-4,886,169USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30478,696USD92
2021-01-01 to 2021-09-301,110,791USD273
2020-07-01 to 2020-09-30268,487USD92
2020-01-01 to 2020-09-30871,907USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-07-01 to 2021-09-3010,968USD92
2021-01-01 to 2021-09-3010,968USD273
2020-07-01 to 2020-09-301,532USD92
2020-01-01 to 2020-09-3010,724USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-01-01 to 2021-09-30342,959USD273
2020-01-01 to 2020-09-30318,609USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-73,964USD92
2021-01-01 to 2021-09-30418,253USD273
2020-07-01 to 2020-09-30-957,752USD92
2020-01-01 to 2020-09-30-2,696,548USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-3025,821USD273
2020-01-01 to 2020-09-3041,527USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-34,267USD273
2020-01-01 to 2020-09-300USD274

Inspect the source

Entity
CEN BIOTECH, INC. / CIK 0001653821
Captured
SEC response SHA-256
097c84c6c785c728d94a8aab95d5185c6c0595b9a921b7610327e115a19292be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001653821.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))